Literature DB >> 3978876

New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

M T Labro-Bryskier, C Babin-Chevaye, J Hakim.   

Abstract

Twenty-two SLE sera were assessed for their stimulating properties for lymphocytes. After fixation of specific serum factors, lymphocyte cultures were performed and supernatants of 24, 48, 72 and 96 h tested on two polymorphonuclear functions: chemotaxis and cyanide insensitive O2 consumption; 20 out of 22 SLE sera supernatants led to enhanced chemotaxis. The factors involved were not destroyed by heating for 30 min at 56 degrees C. Fifteen of the SLE sera supernatants increased the O2 consumption by PN. In most cases this second mediator was destroyed by heating. The buffer, the normal sera, the monoclonal antibodies stimulated lymphocytes supernatants and the total lymphocyte lysate did not display such enhancing activities. So it clearly appears that SLE sera contain factors acting on lymphocyte membrane and induce them to secrete new lymphokines called PNAF (polymorphonuclear activating factors) which may play a role in pathogenesis of tissue lesions in SLE.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978876      PMCID: PMC1577131     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Antibodies for T lymphocytes in systemic lupus erythematosus.

Authors:  G Michlmayr; C Pathouli; C Huber; H Huber
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  Chemotaxis inhibition induced in polymorphonuclear neutrophils by soluble immune complexes.

Authors:  J Leung-Tack; J Maillard; G A Voisin
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

3.  Lymphocyte and platelet autoantibodies in S.L.E.

Authors:  P Stastny; M Ziff
Journal:  Lancet       Date:  1971-06-12       Impact factor: 79.321

4.  Spontaneous lymphokine production by human B lymphocytes.

Authors:  H Arvilommi; L Räsänen; A Laatikainen; E Karhumäki
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-04

5.  Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies.

Authors:  C Morimoto; E L Reinherz; T Abe; M Homma; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1980-08

6.  Oxy radicals and connective tissue.

Authors:  R A Greenwald
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

7.  Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases.

Authors:  A L Schocket; P F Kohler
Journal:  Arthritis Rheum       Date:  1979-10

8.  Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis.

Authors:  E Feliu; M A Gougerot; J Hakim; E Cramer; C Auclair; B Rueff; P Boivin
Journal:  Eur J Clin Invest       Date:  1977-12       Impact factor: 4.686

9.  Anti-Ia reactivity in sera from patients with systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; J L Ceuppens; J S Goodwin; R C Williams
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  Antilymphocyte antibodies in progressive systemic sclerosis.

Authors:  M T Labro; A Perianin; M F Kahn
Journal:  Clin Exp Rheumatol       Date:  1983 Jan-Mar       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.